| Identification | Back Directory | [Name]
[2(S)-cis]-Octahydro-gamma-oxo-alpha-(phenylmethyl)-2H-isoindole-2-butanoic acid | [CAS]
145375-43-5 | [Synonyms]
MITIGLINIDE Unii-D86I0xlb13 Mitiglinide [inn] Mitiglinide (S21403) Mitiglinide Impurity Ⅱ [2(S)-cis]-Octahydro-γ-oxo-α-(phenylmethyl)-2H-isoindole-2-butanoic acid (2S)-4-[(3aR,7aS)-octahydro-1H-isoindol-2-yl]-2-benzyl-4-oxobutanoic acid 2H-Isoindole-2-butanoic acid, octahydro-γ-oxo-α-(phenylmethyl)-, (αS,3aR,7aS)- [2(s)-cis]-octahydro-gamma-oxo-alpha-(phenylmethyl)-2h-isoindole-2-butanoic acid [2(S)-cis]-Octahydro-gamma-oxo-alpha-(phenylmethyl)-2H-isoindole-2-butanoic acid USP/EP/BP | [EINECS(EC#)]
1312995-182-4 | [Molecular Formula]
C19H25NO3 | [MDL Number]
MFCD08458378 | [MOL File]
145375-43-5.mol | [Molecular Weight]
315.41 |
| Chemical Properties | Back Directory | [alpha ]
D24 -3.2° (c = 1.04 in methanol); D18 -3.5° (c = 1.00 in methanol) | [Boiling point ]
519.6±43.0 °C(Predicted) | [density ]
1.175 | [pka]
4.37±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
Antineoplastic. | [Definition]
ChEBI: Mitiglinide is a monocarboxylic acid and a member of benzenes. | [in vivo]
Mitiglinide (1-3 mg/kg; p.o.) suppresses the increase in plasma glucose levels seen after a meal load and the area under the curve for plasma glucose levels (AUCglucose) up to 5 h after the meal load[2].
| Animal Model: | Pregnant Wistar rats (12 weeks)[2] | | Dosage: | 0.3 mg/kg, 1 mg/kg, 3 mg/kg | | Administration: | Oral administration | | Result: | Dose-dependently suppressed AUCglucose levels. |
|
|
|